Viatris VTRS
NASDAQ VTRS
$16.45 -0.16 (-0.93%)
As of: Sep 9, 2026 · 3:08 PM EDT

Viatris (VTRS) Change in Account Payables (2020 - 2026)

Viatris (VTRS) posted Change in Account Payables of -$21.2 million for Q2 2026, down 164.83% on a QoQ basis from $32.7 million in Q1 2026, and up 92.72% year-over-year from -$11.0 million in Q2 2025.

Analysis

Viatris (VTRS) Change in Account Payables (2020 - 2026) Analysis & Trends

Viatris has reported Change in Account Payables for 7 years, with the latest figure at -$21.2 million in Q2 2026.

  • On a quarterly basis, Change in Account Payables rose 92.72% year-over-year to -$21.2 million in Q2 2026; TTM through Jun 2026 was $33.2 million, a 115.81% increase from a year earlier, with the FY2025 full-year figure at -$168.0 million, down 566.67% from the prior year.
  • Change in Account Payables was -$21.2 million for Q2 2026 at Viatris, down from $32.7 million in the prior quarter.
  • The five-year high for Change in Account Payables was $287.9 million in Q1 2024, with the low at -$329.9 million in Q3 2022.
  • Average Change in Account Payables over 5 years is $20.2 million, with a median of $25.6 million recorded in 2025.
  • The sharpest annual moves came in 2023 and 2024: Change in Account Payables jumped 707.28% in 2023, then sank 2590.32% in 2024.
  • Over 5 years, Change in Account Payables stood at $245.6 million in 2022, then slumped by 68.08% to $78.4 million in 2023, then plunged by 41.71% to $45.7 million in 2024, then plunged by 59.52% to $18.5 million in 2025, then slumped by 214.59% to -$21.2 million in 2026.
  • The last three Change in Account Payables figures came in at -$21.2 million (Q2 2026), $32.7 million (Q1 2026), and $18.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Teva Pharmaceutical Industries 42.53 Bn 38.88 Bn 2.15 Bn -
2 Viatris 19.14 Bn 18.25 Bn 1.46 Bn -21.20 Mn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 45.25 Mn
4 Amneal Pharmaceuticals 5.45 Bn 5.33 Bn 334.51 Mn -8.53 Mn
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn -
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn 30.70 Mn
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn -1.12 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 400.20 Mn 358.95 Mn 17.15 Mn -
10 RedHill Biopharma 178.79 Mn 178.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.20 Mn
Mar 31, 2026 32.70 Mn
Dec 31, 2025 18.50 Mn
Sep 30, 2025 3.20 Mn
Jun 30, 2025 -291.30 Mn
Mar 31, 2025 101.60 Mn
Dec 31, 2024 45.70 Mn
Sep 30, 2024 -66.00 Mn
Jun 30, 2024 -231.60 Mn
Mar 31, 2024 287.90 Mn
Dec 31, 2023 78.40 Mn
Sep 30, 2023 43.60 Mn
Jun 30, 2023 9.30 Mn
Mar 31, 2023 183.40 Mn
Dec 31, 2022 245.60 Mn
Sep 30, 2022 -329.90 Mn
Jun 30, 2022 284.70 Mn
Mar 31, 2022 -30.20 Mn
Dec 31, 2021 38.00 Mn
Sep 30, 2021 -54.90 Mn